Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

Share Price is delayed by 15 minutes
Get Live Data
200.00    0.00 (0.00%)
Bid:
195.00
Ask:
205.00
Spread: 10.00 (5.128%)
Market Cap: £34.01m
SNX Live PriceLast checked at - London Stock Exchange

Intraday Synectics Share Chart

Director/PDMR Shareholding

26 May 2017 10:04

RNS Number : 3622G
Synectics PLC
26 May 2017
 

 

26 May 2017

 

 

 

Synectics plc

(the "Company")

Director / PDMR shareholding

 

The Company announces that on 24 May 2017 the Trustee of the Company's HMRC Approved Employee Share Acquisition Plan ("ESAP") reinvested the Company's final dividend and allocated a total of 638 ordinary shares of 20 pence each in the Company to ESAP participants. The shares were purchased on 24 May 2017 at a price of £2.23 per share.

As a result, the Company has been notified that Paul Webb and Mike Stilwell, directors of the Company, have acquired an interest in 44 shares and 24 shares respectively. The resultant interests of Paul Webb and Mike Stilwell are as follows:

 

Name

Position

Ordinary shares held

Interest in shares in Share Schemes

ResultantTotalInterest

% ofIssuedShare Capital

Paul Webb

Chief Executive

10,000

300,391

310,391

1.74%

Mike Stilwell

Finance Director

6,910

50,671

57,581

0.32%

 

For further information, please contact:

Synectics plc

Tel: +44 (0) 1527 850 080

Richard Brierley, Company Secretary

legalandsecretarial@synecticsplc.com

www.synecticsplc.com

Stockdale Securities

Tel: +44 (0) 20 7601 6100

Tom Griffiths / Henry Willcocks

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEANSKAEFXEEF
Date   Source Headline
22nd Apr 200512:55 pmRNSAcquisition
11th Feb 20054:55 pmRNSHolding in Company
7th Feb 20052:14 pmRNSHolding(s) in Company
31st Jan 20057:01 amRNSInterim Results
24th Jan 20055:21 pmRNSNotice of Results
7th Jan 20054:13 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.